GB Sciences Inc (GBLX)

[3DYOGI]

GB Sciences is a OTCQB a fully reporting company not a pink sheet.

Has a small float FDA Parkinson's program in the following months

Perhaps the single most significant development is the work of Dr. Andrea Small-Howard and her team of scientists to define and articulate the real potential of our research. Working with our intellectual property attorneys at Fenwick&West, the science team has carefully defined at least eight potential patents for cannabis-based compounds to treat illnesses and serious, life-changing medical conditions.

The developments I have just described above comprise the "Life Sciences" opportunity. I am quite confident the Life Sciences has the potential to become a billion dollar in sales company on its own

We also continue to have a "cannabis as consumer product" opportunity. The foundation that we are building for our Life Sciences opportunity also will serve us well in our Consumer Product opportunity. Quite simply, we are already working to acquire various categories of cannabis licenses in California, Texas and Pennsylvania to name a few. Our vision is to create a national footprint and offer nationally-recognized high quality brands of cannabis products. Interestingly, we have found that our work in the Life Sciences and the quality of our cultivation and production facilities has made state regulators in target states much more receptive to the Company than a "plain old cannabis company".

So, the dual strategy of both creating medicines and producing high-quality consumer products fuels our confidence that consumer products is the second "billion dollar" opportunity.

a motion was made to change the name of the Company from Growblox Sciences, Inc. to GB Sciences, Inc. This motion also passed, but its implementation is subject to FINRA and SEC approval.


GB Science will not expend additional capital on Growblox devices.

http://growblox.com/gbs-production/2015-product-line.html

https://www.greenrushdaily.com/2017/01/18/investment-experts-predict-explosive-year-cannabis/



According to Robinson, there have been 64 cannabis companies that have had stock growth of over 1,000%. But he said it gets it even better.

Eleven of those 64 companies saw their stocks rise above 10,000% growth. Stocks in 5 of those companies rose more than 25,000%. Three of them went over 50,000%. And one cannabis company’s stock increased by more than 130,000%.


CNBX 360 Million Market Cap
CBIS 215 Million Market Cap
OWCP 200 Million Market Cap
AXIM 441 Million Market Cap
GBLX 40 Million Market Cap

(small float are float is smaller than all the above and we have more cash than peers in medical marijuana sector)

GB Sciences Seeks Patent for Cannabis-based Treatment for Bowel Diseases

https://ibdnewstoday.com/2017/02/07/gb-sciences-seeks-patent-for-marijuana-based-therapy-for-inflammatory-bowel-diseases/


Growblox Sciences Announces Patent Application for Treatments of Parkinson's Disease, Alzheimer's Disease, Huntington's Disease and Dementia


www.prnewswire.com/news-releases/growblox-sciences-announces-patent-application-for-treatments-of-parkinsons-disease-alzheimers-disease-huntingtons-disease-and-dementia-300343440.html

GB Sciences Licenses Patent To Develop New Cannabis-Based Therapies For The Treatment Of Heart Disease.